HCR Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$284K Sell
5,913
-1,672
-22% -$71.8K 0.03% 217
2026
Q1
$279K Sell
7,585
-2,755
-27% -$131K 0.03% 203
2025
Q4
$526K Sell
10,340
-7,813
-43% -$400K 0.05% 146
2025
Q3
$1.07M Buy
18,153
+240
+1% +$14K 0.11% 102
2025
Q2
$1.24M Buy
17,913
+3,430
+24% +$233K 0.15% 91
2025
Q1
$1.01M Buy
14,483
+2,763
+24% +$228K 0.13% 99
2024
Q4
$1.01M Sell
11,720
-234
-2% -$25.3K 0.13% 100
2024
Q3
$1.42M Buy
11,954
+3,227
+37% +$430K 0.19% 84
2024
Q2
$1.25M Buy
8,727
+1,358
+18% +$180K 0.18% 82
2024
Q1
$946K Buy
+7,369
New +$877K 0.14% 99

Other funds holding NVO